ABSTRACT: Two fibrinogenolytic enzymes, Bothrops alternatus metalloprotease isoform (BaltMP)-I and II, were purified from Bothrops alternatus venom using Diethylaminoethyl (DEAE) Sephacel, Sephadex G-75 and Heparin-Agarose column chromatography. Purified BaltMP-I and II ran as single protein bands on analytical polyacrylamide gel electrophoresis and showed molecular weights of 29000 and 36000, respectively, under reducing conditions in sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). BaltMP-II, but not BaltMP-I, displayed blood-clotting activity in bovine plasma, which was about 10-fold higher than that of the crude venom. Both enzymes were proteolytically active against bovine fibrinogen as substrate. When fibrinogen and each enzyme were incubated at 37°C, at a ratio of 1:100 (w/w), BaltMP-II cleaved preferentially the Aα-chain and more slowly the Bβ-chain. The action of BaltMP-I was similar, but lower. None of the proteases degraded the γ-chain of fibrinogen. The fibrinogenolytic activity of the enzymes was inhibited by 1,10-phenanthroline, suggesting they are metalloproteases. Since both enzymes were found to cause defibrinogenation when intraperitoneally (i.p.) administered to mice, they can be of medical interest as a therapeutic agent in the treatment and prevention of arterial thrombosis.
INTRODUCTION
Bothrops snake venoms contain several different proteins affecting the hemostatic mechanism. Some of them display pro and anticoagulant activities (15, 33, 38) . Other components are able to affect platelet function, acting either as pro-aggregating inducers or as platelet inhibitors, whereas others produce vasodilation (6, 11, 18, 19, 23, 39) . According to their interaction with inhibitors, pro and anticoagulant components in snake venoms are divided into serine and metalloproteases (1, 20, 34, 37) . Direct fibrin(ogen)olytic metalloproteases degrade preferentially the Aα-chain of fibrinogen followed by the β-chain. The enzymes degrading the β-chain without fibrinolysis belong to the serine proteases group (17) . Some metalloproteases have fibrinogenolytic or fibrinolytic activities and are named fibrinogenases. These enzymes have been classified as α, β and γ-fibrinogenases (24, 26, 28, 32) showing that they are structurally related (20, 25, 29) .
Recently, a 60kDa hemorrhagic metalloprotease, BjussuMP-I, has been isolated from Bothrops jararacussu venom. Because platelets play a crucial role in hemostasis and are targets of metalloproteases disintegrin-like/disintegrins, BjussuMP-I has been investigated as inhibitor of platelet aggregation and its deduced full-length sequence by cDNA cloning has also been reported (21, 22) .
Proteinases with fibrin(ogen)olytic and anti-clotting properties find potential application in drug development to treat thrombotic disorders which result in fatal heart attack and stroke. The current paper describes the purification and functional characterization of two proteolytic enzymes, called BaltMP-I and II, from the venom of Bothrops alternatus as well as some results of their biochemical characterization including blood-clotting, fibrinogenolytic and defibrinating activities.
MATERIALS AND METHODS

Materials
Bothrops alternatus dried venom was obtained from the Reptiles Sector at Federal University of Uberlândia, Brazil. Bovine fibrinogen, aprotinin, phenylmethylsulfonyl fluoride (PMSF), ethylenediaminetetraacetate (EDTA), 1,10-phenanthroline and β-mercaptoethanol were from Sigma (USA). All other chemicals were of analytical grade.
Isolation of BaltMP-I
Bothrops alternatus venom (200mg) was dissolved in 50mM ammonium bicarbonate buffer, pH 7.8, and clarified by centrifugation at 10000Xg for 10 min. The supernatant solution was chromatographed on a DEAE-Sephacel column (1.7X15cm), previously equilibrated with 50mM ammonium bicarbonate, pH 7.8, and eluted with convex concentration gradient (50mM-1M) of the same buffer. Fractions of 3ml/tube were collected, their absorbances at λ=280nm were read and those corresponding to peak D6 were all together lyophilized, dispersed in 50mM ammonium bicarbonate, pH 7.8, and applied to a Sephadex G-75 column (2X100cm) previously equilibrated with the same buffer. To isolate BaltMP-I, the fibrinogenolytic fraction (peak D6G2) was lyophilized and applied to a Heparin-Agarose column (1.7X15cm) previously equilibrated with 10mM Tris-HCl + 5mM CaCl 2 , pH 7, and eluted with 10mM Tris-HCl + 1M NaCl, pH 7. The flow rate was 40ml/h and 2ml fractions were collected. The isolated enzyme was named B. alternatus metalloprotease I (BaltMP-I).
Isolation of BaltMP-II
To isolate BaltMP-II, the protein fractions (peak D3) showing fibrinogenolytic and blood-clotting activities were pooled, lyophilized and dissolved in 3ml of distilled water. This sample was applied to a Sephadex G-75 column (2X100cm), equilibrated and eluted with 50mM ammonium bicarbonate, pH 7.8. The flow rate was 20ml/h and 3ml fractions were collected. The isolated enzyme was named B. alternatus metalloprotease II (BaltMP-II).
Electrophoretic Analysis: Molecular Weight Determination
The molecular weights of BaltMP-I and II were determined using SDS-PAGE (14%) according to the method of Laemmli (13) . Electrophoresis was carried out at 20mA/gel in Tris-glycine buffer, pH 8.3, containing 0.01% SDS. The molecularweight standard proteins used were phosphorylase b (97000), bovine serum albumin (66000), ovoalbumin (45000), carbonic anhydrase (30000), soybean trypsin inhibitor (20100), and α-lactalbumin (14400). The slab gels were stained with Coomassie Blue R-250, 0.2% (w/v), in acetic acid : methanol : water (1 : 5 : 5, v/v).
Estimation of Protein Concentration
Protein concentration was determined according to a micro-biuret method (10), using bovine serum albumin as standard.
Fibrinogenolytic Activity
Fibrinogenolytic activity was assayed as previously described (25) . Fibrinogen (5μg) and enzymes were mixed 1:100 (w/w) and the mixture was incubated at 37ºC for different time intervals (0-90 min). The reaction was stopped by the addition of an equal volume of a denaturing buffer containing 2% (w/v) SDS and 10% (v/v) β-mercaptoethanol. The reaction products were analyzed using SDS-PAGE and 14% gels.
Defibrinating Activity
Defibrinating activity was tested using the method of Gene et al. 
Blood-Clotting Activity
Blood samples were collected into 3.8% sodium citrate (9:1, v/v) and centrifuged at 2500Xg for 15 min at 4°C to obtain platelet-poor plasma. Clotting activity was determined by mixing 5μg of enzymes with 200μl of citrated bovine plasma at 37ºC and by determining the clotting time.
Enzyme Inhibitors
Inhibition of fibrinogenolytic activity was determined by incubating enzymes (5μg) in 200μl of 50mM Tris-HCl, pH 7.8, for 15 min at room temperature (25°C) with one of the following inhibitors: 10mM EDTA, 10mM PMSF, 10mM aprotinin, 10mM 1,10-phenanthroline, and 10mM β-mercaptoethanol. Proteolytic activity was determined as previously described.
RESULTS
Isolation of BaltMP-I and II
Bothrops alternatus venom, initially fractionated on DEAE-Sephacel column, displayed six peaks, D1-D6. A typical elution profile of this chromatography is shown in Figure 1A . Fraction D6 was further purified on a Sephadex G-75 column ( Figure   1B ). Fraction D6G2 from this fractionation was applied to a Heparin-Agarose column proteases, namely β-mercaptoethanol, PMSF and aprotinin, had little or no effect on the fibrinogenolytic activity of BaltMP-I and II. EDTA was able to abolish the activity of BaltMP-II but had no effect on that of BaltMP-I.
Blood-Clotting and Defibrinating Activities of BaltMP-I and II
BaltMP-II, but not BaltMP-I, displayed a blood-clotting activity on bovine plasma, which was about 10-fold higher than that of the crude venom.
In addition, BaltMP-I and II caused defibrinogenation when i.p. administered to mice, making the plasma uncoagulable. Fibrinogen levels became very low one hour after injection of 5μg of each enzyme. Normal fibrinogen levels were only reestablished after 24 hours. 
DISCUSSION
The main feature of B. alternatus venom is its high proteolytic activity, responsible for most of the local and systemic effects observed during envenomation by this snake.
In the present work, BaltMP-I and II, two proteases active on fibrinogen, were isolated using chromatography on DEAE-Sephacel, Sephadex G-75 and HeparinAgarose. Both enzymes were devoid of hemorrhagic and phospholipase-A 2 activities but displayed fibrinogenolytic and defibrinogenation activities. Only BaltMP-II exhibited blood-clotting activity.
The final preparations of BaltMP-I and II were analyzed using SDS-PAGE under reducing conditions. In both cases, the isolated enzymes appeared as single protein bands with molecular weights of 29000 and 36000, respectively (the calibration curve for estimation of molecular weights is not shown). Such observations indicate that the isolated enzymes are composed of single polypeptide chains.
Based on their domain structure, snake venom metalloproteases (SVMPs) have been classified into four classes, P-I to P-IV (9, 20) . Metalloproteases of P-I class consist only of the protease domain, those of class P-II consist of protease domain and disintegrin-like domain, and those of class P-III have a third, cysteine-rich domain. Class P-IV SVMPs possess, in addition to class P-III domains, disulfideattached lectin-like domains. Sub-class P-IA proteins display high hemorrhagic activity, whereas those of class P-IB display little or no activity and include neuwiedase from Bothrops neuwiedi venom (29), MOO3 from Bothrops moojeni venom (8) and adamalysin II from Crotalus adamanteus venom (27) . The present results suggest that BaltMP-I and II belong to class PI-B. The PI-B SVMPs can also display fibrinogenolytic activity with specificity for the Aα-chain and they lack arginine-esterase activity.
The fibrinogenolytic activity of both enzymes was analyzed using SDS-PAGE, which demonstrated that they were able to degrade fibrinogen chains, BaltMP-II being most active. BaltMP-I and II showed fibrinogenolytic activity, degrading predominantly the Aα-chain of fibrinogen and, at longer incubation times, the Bβ-chain as well.
Furthermore, the fibrinogenolytic products of BaltMP-I revealed a different cleavage pattern compared with BaltMP-II.
Based on the preferential attack on Aα or Bβ-chain of fibrinogen, venom fibrinogenases can be either α or β-type. The α-fibrinogenases preferentially attack the Aα-chain and are metalloproteases. They also cleave the Bβ-chain, but at a slower rate, whereas β-fibrinogenases are serine proteases and show arginineesterase activity (12, 36) . In the current study, results suggested that BaltMP-I and II are α-fibrinogenases.
BaltMP-I and II did not digest the γ-chain, which is common to many venom proteases. This digestion pattern is similar to that of many fibrinogenases isolated from snake venoms, such as that purified from B. moojeni (8) and B. neuwiedi pauloensis (29) . Figure 3 shows the effect of inhibitors of the fibrinogenolytic activity of BaltMP-I and II. Aprotinin is well known for inactivating trypsin, kallikrein, chymotrypsin, and plasmin (3); however, it showed no effect on the fibrinogenolytic activity of BaltMP-I and II. Phenylmethylsulfonyl fluoride (PMSF) appeared to have little or no effect on the fibrinogenolytic activity of BatMP-I and II, indicating that both enzymes are not serine proteases. Their fibrinogenolytic activity was inhibited by chelating compounds such as 1,10-phenanthroline, but BaltMP-I was more strongly inhibited than BaltMP-II.
1,10-phenanthroline is highly specific for Zn 2+ . Ca 2+ forms weak complex with 1,10-phenanthroline. Although the Zn 2+ -specific reactivity of 1,10-phenanthroline inactivates BaltMP-I, it is surprising to note the ineffectiveness of EDTA which, like 1,10-phenanthroline, shows preference and more affinity for Zn 2+ than for Ca 2+ .
These results indicated that both BatMP-I and II belong to the metalloproteases family, but have different inhibitor susceptibilities.
Several proteases from snake venoms have potential clinical usefulness for the treatment of human diseases, used as defibrinogenating agents, and are largely used in laboratories for the detection of fibrinogen in samples of heparinized blood (30) . These enzymes have been purified from several different snake species (16, 30) .
BaltMP-I and II have been shown to induce defibrinogenation. Both enzymes act as benign defibrinogenating agents to remove fibrinogen from the blood. Within minutes of administration of both enzymes there was a depression in the fibrinogen concentration in plasma and within one hour the fibrinogen levels became very low and thus remained for more than 24 hours. These results suggest that the anticoagulant effect of BaltMP-I and II could be attributed to its proteolytic action on fibrinogen, forming fibrin monomers (non cross-linked fibrin), which could be rapidly removed from the circulation (14) .
Some fibrin(ogen)olytic enzymes cause rapid defibrinogenation when they are intravenously administered, reducing the whole blood viscosity (2, 4, 31) and increasing blood flow (5).
Some of these proteases from snake venoms have been used as defibrinogenating agents for a number of clinical conditions including deep vein thrombosis, myocardial infarction, pulmonary embolus, peripheral vascular disease, angina pectoris, surgical adhesives and renal transplant rejection (30, 31, 35) . For this reason, these enzymes have been considered of great interest to medical clinic, mainly those with high degree of purity and devoid of other pharmacological effects.
In conclusion, two metalloproteases, BaltMP-I and II, were purified from the venom of Bothrops alternatus. Both showed to possess α-fibrinogenase activity and strong in vivo anticoagulant properties. Further structure-function studies on theses enzymes are interesting and would probably help develop therapeutic agents related to thrombotic disorders.
